Item 9 Labs Corp (INLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2022 | 09-2021 | 09-2020 | 09-2019 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 86 | 1,455 | 85 | 575 | 1,674 |
| Receivables | 586 | 1,448 | 353 | 437 | 736 |
| Inventories | 2,464 | 6,391 | 2,147 | N/A | N/A |
| Other current assets | 0 | 0 | 0 | 1,937 | 844 |
| TOTAL | $3,553 | $10,097 | $2,892 | $2,963 | $3,261 |
| Non-Current Assets | |||||
| PPE Net | 21,020 | 10,878 | 7,209 | 7,170 | 1,234 |
| Investments And Advances | 0 | 0 | 0 | 100 | 100 |
| Intangibles | 69,975 | 76,724 | 8,882 | 2,956 | 0 |
| Other Non-Current Assets | 16,214 | 19,111 | 1,681 | 1,285 | 449 |
| TOTAL | $107,208 | $106,713 | $17,772 | $11,511 | $1,783 |
| Total Assets | $110,762 | $116,809 | $20,664 | $14,474 | $5,044 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,422 | 3,760 | 1,977 | 1,077 | 726 |
| Accrued Expenses | 8,485 | 5,240 | 2,788 | 1,202 | 147 |
| Other current liabilities | 5,500 | N/A | N/A | N/A | N/A |
| TOTAL | $40,586 | $14,990 | $10,289 | $7,138 | $981 |
| Non-Current Liabilities | |||||
| Long Term Debt | 7,217 | 14,957 | 2,220 | N/A | 1,500 |
| Deferred Revenues | 220 | 120 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 719 | 104 | 167 | 124 | 0 |
| TOTAL | $8,235 | $15,718 | $2,360 | $N/A | $1,500 |
| Total Liabilities | $48,821 | $30,708 | $12,649 | $7,138 | $2,481 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 100,002 | 94,917 | 62,715 | 63,653 | N/A |
| Common Shares | 11 | 11 | 7 | 6 | 6 |
| Retained earnings | -65,017 | -33,874 | -22,968 | -10,695 | -870 |
| Other shareholders' equity | -471 | -450 | -450 | -124 | 0 |
| TOTAL | $61,941 | $86,101 | $8,015 | $7,336 | $2,563 |
| Total Liabilities And Equity | $110,762 | $116,809 | $20,664 | $14,474 | $5,044 |